The research demonstrated that anemia was not only the most prevalent hematologic abnormality but also the most dangerous. Patients with anemia were four times more likely to die from EVD compared to ...

Former President Sirleaf launches a book on Liberia's fight against Ebola, as she reflects on resilience of the population ...

Announcing a new article publication for Zoonoses journal. Hematologic disorders occur frequently in patients with Ebola ...

The treatment, an oral antiviral called obeldesivir, prevented up to 100% of deaths in monkeys given a high dose of the deadliest species of Ebola. These findings and others suggest that ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

The pill protected 80 per cent of the cynomolgus macaques and 100 per cent of the rhesus macaques, which are biologically closer to humans.

Monkeys infected with the deadly Ebola virus have been successfully cured by a 10-day regimen of pills, leading scientists to hope the treatment could be adapted for use in humans. The drug ...

Eight infected people were found and the patients underwent treatment at the Ebola Treatment Unit in Kampala and Mbale Regional Referral Hospital in eastern Uganda. Over 200 contacts were also ...

A day after getting exposed to the Ebola virus, ten monkeys then received an Obeldesivir pill daily for ten days, while three control monkeys received no treatment and died. The study found that ...

On a November morning in 2018, a man checked into a crowded emergency department (ED) in California reporting fever and body ...